These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9455499)

  • 21. Identification of patients at high risk of graft loss by pre- and posttransplant monitoring of anti-HLA class I IgG antibodies by enzyme-linked immunosorbent assay.
    Monteiro F; Buelow R; Mineiro C; Rodrigues H; Kalil J
    Transplantation; 1997 Feb; 63(4):542-6. PubMed ID: 9047148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical relevance of anti-HLA antibodies pre and post transplant.
    Kerman RH; Orosz CG; Lorber MI
    Am J Med Sci; 1997 May; 313(5):275-8. PubMed ID: 9145036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation.
    Jaramillo A; Smith MA; Phelan D; Sundaresan S; Trulock EP; Lynch JP; Cooper JD; Patterson GA; Mohanakumar T
    Transplantation; 1999 Apr; 67(8):1155-61. PubMed ID: 10232567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative evaluation of ELISA and Luminex panel reactive antibody assays for HLA alloantibody screening].
    Jung S; Oh EJ; Yang CW; Ahn WS; Kim Y; Park YJ; Han K
    Korean J Lab Med; 2009 Oct; 29(5):473-80. PubMed ID: 19893358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between enzyme-linked immunosorbent assay and cytotoxic cross-match procedures for detecting IgG anti-donor antibodies.
    Susskind B; Kerman RH; Nelson R; Gregory J; La T; Bayat A; Dang M; Van Buren C; Katz S; Kahan BD
    Transplantation; 1998 Dec; 66(12):1823-6. PubMed ID: 9884282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of HLA-class I alloantibodies using PRA-STAT and complement-dependent cytotoxicity techniques.
    Papassavas AC; Iniotaki-Theodoraki A; Stathakopoulou A; Ioannou S; Kostakis A; Stavropoulos-Giokas C
    Transplant Proc; 1998 May; 30(3):724-6. PubMed ID: 9595073
    [No Abstract]   [Full Text] [Related]  

  • 27. Soluble HLA antigens and ELISA--a new technology for crossmatch testing.
    Buelow R; Chiang TR; Monteiro F; Cornejo MC; Ellingson L; Claas F; Gaber O; Gelder F; Kotb M; Orosz C
    Transplantation; 1995 Dec; 60(12):1594-9. PubMed ID: 8545896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants.
    Kim Y; Yang CW; Moon IS; Kim M; Lim J; Park YJ; Han K; Oh EJ
    Ann Clin Lab Sci; 2010; 40(4):330-5. PubMed ID: 20947806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of donor-specific anti-HLA class I and II antibodies using antibody monitoring system.
    Yang CW; Oh EJ; Lee SB; Moon IS; Kim DG; Choi BS; Park SC; Choi YJ; Park YJ; Han K
    Transplant Proc; 2006 Nov; 38(9):2803-6. PubMed ID: 17112834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.
    Rasmussen M; Dahl M; Buus S; Djurisic S; Ohlsson J; Hviid TV
    Tissue Antigens; 2014 Aug; 84(2):206-15. PubMed ID: 24785939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA and MICA allosensitization patterns among patients supported by ventricular assist devices.
    Askar M; Hsich E; Reville P; Nowacki AS; Baldwin W; Bakdash S; Daghstani J; Zhang A; Klingman L; Smedira N; Moazami N; Taylor DO; Starling RC; Gonzalez-Stawinski G
    J Heart Lung Transplant; 2013 Dec; 32(12):1241-8. PubMed ID: 24075503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification and identification of soluble HLA-G isoforms.
    Rebmann V; LeMaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
    Tissue Antigens; 2007 Apr; 69 Suppl 1():143-9. PubMed ID: 17445190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M; Hung CJ; Lin YJ; Chang SS; Chou TC
    Transplant Proc; 2009; 41(1):95-8. PubMed ID: 19249487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of soluble HLA-G molecules in plasma and amniotic fluid.
    Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H
    Tissue Antigens; 1999 Jan; 53(1):14-22. PubMed ID: 10082427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An EIA method on single donor solubilized HLA antigens for the identification of anti-HLA antibodies.
    Emonds MP; Claeys H; Volckaerts A; Dendievel J; Vermylen C
    Clin Lab Haematol; 1997 Jun; 19(2):129-36. PubMed ID: 9218153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
    Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM
    Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-HLA antibodies in nephropathic patients].
    Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
    G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.